BML Capital Management, LLC - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 62 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
BML Capital Management, LLC ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,039,172
-33.0%
781,292
-8.1%
1.87%
-31.6%
Q2 2023$3,043,000
+2.9%
850,000
-37.3%
2.74%
+7.1%
Q1 2023$2,955,9171,355,9252.56%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
BML Capital Management, LLC 781,292$2,039,1721.87%
GSA CAPITAL PARTNERS LLP 88,923$2320.02%
Glass Jacobson Investment Advisors llc 12,255$31,9860.02%
Rathbones Group PLC 289,803$756,3860.01%
N.E.W. Advisory Services LLC 12,960$33,8260.01%
Virtu Financial LLC 17,388$450.00%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$14,6870.00%
ALGERT GLOBAL LLC 14,680$380.00%
Close Asset Management Ltd 11,400$300.00%
Altshuler Shaham Ltd 12,847$33,4080.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders